BIODEXA PHARMACEUTICALS PLC (BDRXXXXX)
Institutional ownership reported to the SEC as of Q2 2023, across 2 quarters.
8
Reporting holders
$45.8K
Reported value
0.0%
Held as options
+4
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | $18.2K | 265,993 | 0.00% | new | NEW |
| MILLENNIUM MANAGEMENT LLC | $14.0K | 204,300 | 0.00% | 2q | +456.3%+$11.5K |
| UBS Group AG | $9.8K | 142,208 | 0.00% | new | NEW |
| TWO SIGMA SECURITIES, LLC | $2.6K | 37,865 | 0.00% | new | NEW |
| Baader Bank Aktiengesellschaft | $865 | 16,250 | 0.00% | new | NEW |
| RHUMBLINE ADVISERS | $163 | 2,370 | 0.00% | new | NEW |
| MORGAN STANLEY | $94 | 1,368 | 0.00% | 2q | HELD |
| Federation des caisses Desjardins du Quebec | $12 | 180 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 8 | $45.8K | 670,534 | 5 | 1 | 0 | 0.0% |
| Q1 2023 | 4 | $19.0K | 48,806 | 4 | 0 | 0 | 0.0% |